Sculptor Capital LP Protalix Bio Therapeutics, Inc. Put Options Transaction History
Sculptor Capital LP
- $2.76 Billion
- Q3 2024
Put Options
2 transactions
Others Institutions Holding PLX
# of Institutions
51Shares Held
3.47MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.12MShares$2.94 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$982,9800.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$876,2390.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$804,1190.04% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$710,1000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $131M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...